0001683168-22-002865.txt : 20220421 0001683168-22-002865.hdr.sgml : 20220421 20220421214238 ACCESSION NUMBER: 0001683168-22-002865 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220421 FILED AS OF DATE: 20220421 DATE AS OF CHANGE: 20220421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thramann Jeffrey John CENTRAL INDEX KEY: 0001846997 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41358 FILM NUMBER: 22843141 MAIL ADDRESS: STREET 1: 8580 STRAWBERRY LANE CITY: NIWOT STATE: CO ZIP: 80503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aclarion, Inc. CENTRAL INDEX KEY: 0001635077 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 MARINERS ISLAND BLVD STREET 2: STE 300 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 650 241 1740 MAIL ADDRESS: STREET 1: 951 MARINERS ISLAND BLVD STREET 2: STE 300 CITY: SAN MATEO STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: Nocimed, Inc. DATE OF NAME CHANGE: 20150226 3 1 ownership.xml X0206 3 2022-04-21 0 0001635077 Aclarion, Inc. ACON 0001846997 Thramann Jeffrey John C/O ACLARION, INC. 951 MARINERS ISLAND BLVD., SUITE 300 SAN MATEO CA 94404 1 1 0 0 Executive Chairman Employee Stock Option (right to buy) 1.94 2031-09-27 Common Stock 1204819 D The shares under this option became fully vested at the April 21, 2022 effective time of the Company's initial public offering. /s/ Jeffrey Thramann 2022-04-21